Table 2.
IX (n=99) | X (n=84) | p-value | |
---|---|---|---|
CR | 4 (4.0) | 1 (1.2) | |
PR | 40 (40.4) | 27 (32.1) | |
SD | 30 (30.3) | 26 (31.0) | |
PD | 16 (16.2) | 22 (26.2) | |
Not known | 9 (9.1) | 8 (9.5) | |
ORR | 44 (44.4) | 28 (33.3) | 0.30 |
Values are presented as number (%). IX, irinotecan and capecitabine combination; X, capecitabine alone; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate (CR+PR).